1Gadducci A, Baicchi U, Marrai R, et al. Pretreatment plasma levels of fibrinopeptide-A(FPA), D-dimer(DD), and Von Willebrano factor(VWF) in patients with ovarian carcinoma[ J]. Gynecol oncol, 1994,53 : 352.
2Donati MB. Cancer and thrombosis[ J]. Haemostasis, 1994,24(2) : 128.
7Tseng CS, Lo HW, Chen PH, et al. Clinical significance of plasma Ddimer levels and serum VEGF levels in patients with hepatocelular carcinoma[ J ]. Hepatogastroenterology, 2004,51 (59) : 1454.
8Antonious D, Pavlakou G, Stathopoulos GP, et al. Predictive value of Ddimer plasma levels in response and progressive disease in patients with hmg cancer[J]. Lung Cancer,2006,53(2):205.
8Boisclair DA,Lane JT,Wilde HA.A Comparatire evaluatonn of markers of actived coagulation and/or fibrinolysis:thrombin antithrombin complex,D-dimer and Fibrinogen/Fibrin Fragment.Eantigen[J].Br J Haenatol,1990,74(4):471.
9Gadducci A,et al.Pretreatment plasma levels of fibrinopeptide-A (FPA),D-dimer(DD),and Von Willebrano factor(VWF) in patients with ovarlan carcinoma[J].Gynecol oncol 1994,53:352.
10Biggerstaff JP;Seth N;Amirkhosravi A.Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis[J],1999.
4Seebacher V, Poherauer S, Grimm C, et al. The prognostic value of plasma fibrinogen levels in patients with endometrial eancer:a multi -center trial [ J ]. British Journal of Cancer, 2010,102(6) :952-956.
5Poherauer S, Seebacher V, Hefler - Frischmuth K, et al. Fibrlnogen plasma levels are an independent prognostic pa- rameter in patients with cervical cancer [ J ]. Am J Obstet Gynecol,2009,200 (6) : 647.
6Ma Y, Qian Y, Lv W. The correlation between plasma fibrino- gen levels and the clinical features of patients with ovarian carcinoma [ J ]. The Journal of International Medical Research,2007,35:678 - 684.
7Koh SC, Khalil R, Lira FK, et al. The association between fi- brinogen, von Willebrand factor, antithrombin HI, and D - di- mer levels and survival outcome by 36 mouths from ovarian cancer [ J ]. Clin Appl Thromb Hemost,2006,12:3 - 8.
8Sahni A, Francis CW. Vascular endothelial growth factor binds to fibfinogen and fibrin and stimulates endothelial cell proliferation [ J ]. Blood,2000,96 : 3772 - 3778.
9Sahni A, Khorana AA, Baggs RB,et al. FGF- 2 binds to fi- brin (ogen) is required for augmented angiogenesis [ J ]. Blood,2006,107 : 126 - 131.
10Sahni A, Simpson- Haidaris P J, Sahni SK, et al. Fibrino- gen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor - 2 ( FGF - 2 ) [ J ]. J Thromb Haemost ,2008 ,6 : 176 - 183.
